Mahamaya Lifesciences Ltd Financials

Mahamaya Lifesciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Mahamaya Lifesciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	265.75	161.62	137.19
Operating Expenses Annual	241.19	148.15	128.24
Operating Profit Annual	25.87	14.67	9.15
Interest Annual	6.83	5.74	2.62
Depreciation	1.77	1.41	0.83
Net Profit Annual	12.82	5.47	3.73
Tax Annual	4.44	2.05	1.48

Mahamaya Lifesciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	1.09	1.40	0.77
Cash Flow from Operations	-3.35	-23.46	0.81
Cash Flow from Investing	-4.43	-1.38	-2.78
Cash Flow from Financing	8.47	24.53	2.59
Cash Flow at the End	1.78	1.09	1.40

Mahamaya Lifesciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	9.73	9.08	6.75
PBIT Margin (%)	9.07	8.20	5.79
PBT Margin (%)	7.74	6.77	3.67
Net PROFIT Margin (%)	4.82	3.38	2.72
Return On Networth / Equity (%)	34.16	24.37	18.92
Return On Networth /Employed (%)	25.56	21.29	17.89
Return On Assets (%)	13.60	8.80	8.40
Total Debt / Equity (X)	1.50	1.76	1.24
Asset Turnover Ratio (%)	2.82	2.60	3.09

Mahamaya Lifesciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	31.17	24.45	23.52
Total Current Assets Annual	157.04	87.66	54.38
Non Current Assets Annual	31.67	24.83	23.89
Total Shareholders Funds Annual	49.87	25.18	19.71
Total Assets Annual	188.71	112.49	78.27